Gelsolin as therapeutic target in Alzheimer's disease
Authors:
- 23 April 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 14 (6) , 585-592
Abstract
Importance of the field: Fibrillar amyloid beta-protein (Aβ) is a major component of amyloid plaques in the brains of individuals with Alzheimer's disease (AD). However, a comprehensive explanation of the mechanisms leading to brain amyloidosis is still pending. Previous studies have identified the anti-amyloidogenic role of gelsolin in AD. Gelsolin can reduce amyloid burden by acting as an inhibitor of Aβ fibrillization, and as an antioxidant and anti-apoptotic protein.Areas covered in this review: Recent evidence indicates reduced brain gelsolin levels in AD. Therefore, a better understanding of the roles of gelsolin in AD pathology, particularly those related with cognition, is required.What the reader will gain: Most of the information reviewed here relates to experimental studies. However, gelsolin may progress from the present evidence to preclinical and clinical applications. In addition, a greater insight into the environmental factors contributing to abnormally reduced gelsolin function in AD bra...Keywords
This publication has 91 references indexed in Scilit:
- Gelsolin Restores A-Induced Alterations in Choroid Plexus EpitheliumJournal of Biomedicine and Biotechnology, 2010
- Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer’s diseaseBiogerontology, 2008
- Peripheral Transgene Expression of Plasma Gelsolin Reduces Amyloid in Transgenic Mouse Models of Alzheimer's DiseaseMolecular Therapy, 2007
- Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007
- Gelsolin functions as a metasatsis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effectInternational Journal of Cancer, 2001
- Signaling between the actin cytoskeleton and the postsynaptic density of dendritic spinesHippocampus, 2000
- β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: Usage of a novel blood brain barrier endothelial cell model systemAmyloid, 2000
- β‐Thymosin, a modulator of the actin cytoskeleton is increased in regenerating retinal ganglion cellsEuropean Journal of Neuroscience, 1999
- Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude miceCancer Gene Therapy, 1999
- Binding of Gelsolin, a Secretory Protein, to Amyloid β-ProteinBiochemical and Biophysical Research Communications, 1999